Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Abbott's TRILIPIX® (fenofibric Acid) In Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia And Type 2 Diabetes Meet Amer
Abbott"s (NYSE: ABT) TRILIPIX® (fenofibric acid) delayed-release capsules in combination with rosuvastatin calcium achieved individual and combined lipid targets in patients with mixed dyslipidemia and type 2 diabetes. In these patients, the combination of TRILIPIX and rosuvastatin helped up to three times more patients simultaneously reach all three key lipid targets HDL, triglycerides and LDL than the pre-determined monotherapy. Results from this post-hoc analysis were presented at the American Diabetes Association"s 2009 Scientific Sessions.

Linking Genes, Brain, And Behavior In Children
It comes as no surprise that some babies are more difficult to soothe than others but frustrated parents may be relieved to know that this is not necessarily an indication of their parenting skills. According to a new report in Psychological Science, a journal of the Association for Psychological Science, children"s temperament may be due in part to a combination of a certain gene and a specific pattern of brain activity.
News of the day
Fresenius Endorses PEAK Campaign Efforts To Reduce Dialysis Patient Mortality
Fresenius Medical Care, which operates the nation"s leading network of dialysis clinics, today endorsed the Performance Excellence and Accountability in Kidney Care (PEAK) campaign recently launched by Kidney Care Partners (KCP) - a coalition of patient advocates, dialysis professionals, care providers and manufacturers working together to improve quality of care for individuals with chronic kidney disease (CKD). The PEAK initiative is designed to significantly reduce the mortality rate for patients in their first year of dialysis.
Nutrition

Contur Software Adds Further Chemistry Tools To Web-Based ELN

Contur Software, a leading provider of electronic laboratory notebook (ELN) systems, announced added chemistry functionality in iLabber, the company"s recently launched high-end ELN system available as an online service. Using a software as a service (SaaS) model, Contur Software is making iLabber available to individual researchers and smaller R&D organizations that previously have not been able to utilize the advantages of high-end ELN systems due to investments in hardware, licenses and maintenance. The added functionality gives premium users of iLabber access to chemistry drawing, chemical structure and reaction searching, stoichiometric calculations (reaction planning), and iLabber"s inbuilt reagent and reactant databases. All chemistry searching in iLabber is powered by ChemAxon"s JChem Cartridge. In addition, ChemAxon"s MarvinSketch is provided to premium users at no extra cost. ChemAxon is a leading provider of chemical software development platforms for the biotechnology and pharmaceutical industries. "Because ChemAxon technology is well suited for the web the JChem Cartridge is a perfect fit for iLabber" said Alex Drijver, CEO at ChemAxon. "We see extensive possibilities for SaaS in cheminformatics and are happy to be involved in this pioneering project." Starting to use iLabber is easy and users simply download a desktop client. Operation, maintenance and data storage is securely managed by Contur Software. The service is available to individual researchers and smaller research groups (recommended up to 15 users). Individual researchers use iLabber for free, while there is a fee of 60 USD per month and user for commercial organizations. Academic institutions pay only half of that fee. "To smaller research groups with no IT support it is neither economical nor practical to purchase and maintain an in-house database system to gain access to an ELN and all these chemistry tools," said Martin Wattin, CEO at Contur Software. "The advantages of a web-based, yet high-end, ELN solution are indisputable and we have received compelling feedback from users." About Contur Software Contur Software is a privately owned software company founded in 1999. In 2003 the company launched ConturELN, an electronic laboratory notebook system that today is used by many leading organizations around the world. Customers are in the field of Pharma/Biotech, Chemicals and in academia. Contur Software is headquartered in Stockholm, Sweden. http://www.contur.com. ChemAxon


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009